BioXmark® liquid fiducials to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial

por Opbroek, Thirza J.S., Willems, Yves C.P., Verhaegen, Frank, de Ridder, Rogier, Hoge, Chantal, Melenhorst, Jarno, Bakers, Frans, Grabsch, Heike I., Buijsen, Jeroen, Van Limbergen, Evert J., Canters, Richard A.M., Berbée, Maaike
Publicado 2022

Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results

por van den Ende, Roy P. J., Peters, Femke P., Harderwijk, Ernst, Rütten, Heidi, Bouwmans, Liza, Berbee, Maaike, Canters, Richard A. M., Stoian, Georgiana, Compagner, Kim, Rozema, Tom, de Smet, Mariska, Intven, Martijn P. W., Tijssen, Rob H. N., Theuws, Jacqueline, van Haaren, Paul, van Triest, Baukelien, Eekhout, Dave, Marijnen, Corrie A. M., van der Heide, Uulke A., Kerkhof, Ellen M.
Publicado 2020